Novel Adenovirus Vectors ‘Capsid-Displaying’ a Human Complement Inhibitor

Publisher： Karger

E-ISSN： 1662-8128|2|4|353-359

ISSN： 1662-811x

Source： Journal of Innate Immunity, Vol.2, Iss.4, 2010-02, pp. : 353-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcineurin inhibitor‐induced complement system activation via ERK1/2 signalling is inhibited by SOCS‐3 in human renal tubule cells

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 330-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unexpected and Novel Functions of Complement Proteins

By  

Journal of Innate Immunity, Vol. 6, Iss. 4, 2014-05 ,pp. : 405-406

Karger

Access to resources Recommend Favorite

Towards a Novel Vaccine against Human Cytomegalovirus Based on a Chimeric Ad5F35 Adenovirus Vector Expressing the Immunodominant Antigenic Domain 1 Epitope

By  

Intervirology, Vol. 52, Iss. 1, 2009-04 ,pp. : 35-42

Karger

Access to resources Recommend Favorite

The quest for human responsibilities to complement human rights

By Suter Keith  

Medicine, Conflict and Survival, Vol. 26, Iss. 3, 2010-07 ,pp. : 199-206

Routledge Ltd

Access to resources Recommend Favorite

A Novel Thromboxane Synthetase Inhibitor, Dp-1904, Inhibits Human Blood Eosinophil Degranulation

By Agrawal Devendra K.   Takami Mitsutaka   Ono Shin-Etsu  

Inflammation, Vol. 21, Iss. 1, 1997-02 ,pp. : 1-8

Springer Publishing Company

Access to resources Recommend Favorite